Sources of error in measurement of minimal residual disease in childhood acute lymphoblastic leukemia.
The level of minimal residual disease (MRD) in marrow predicts outcome and guides treatment in childhood acute lymphoblastic leukemia (ALL) but accurate prediction depends on accurate measurement.Forty-one children with ALL were studied at the end of induction. Two samples were obtained from each il...
Main Authors: | Sue Latham, Elizabeth Hughes, Bradley Budgen, Francoise Mechinaud, Catherine Crock, Henry Ekert, Peter Campbell, Alexander Morley |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2017-01-01
|
Series: | PLoS ONE |
Online Access: | http://europepmc.org/articles/PMC5626434?pdf=render |
Similar Items
-
Minimal Residual Disease Assessment in Childhood Acute Lymphoblastic Leukemia
by: Thörn, Ingrid
Published: (2009) -
Assessment of minimal residual disease in childhood acute lymphoblastic leukemia
by: Sonia K Parikh, et al.
Published: (2016-01-01) -
CURRENT STRATEGIES FOR THE DETECTION OF MINIMAL RESIDUAL DISEASE IN CHILDHOOD ACUTE LYMPHOBLASTIC LEUKEMIA
by: Juliana Maria Camargos Rocha, et al.
Published: (2016-04-01) -
Circulating microRNAs as minimal residual disease biomarkers in childhood acute lymphoblastic leukemia
by: Andrea Rzepiel, et al.
Published: (2019-11-01) -
Minimal Residual Disease Detection in Acute Lymphoblastic Leukemia
by: Aaron Kruse, et al.
Published: (2020-02-01)